Abstract
A trial fibrillation (AF) has been recognized as a common arrhythmia since it was first described electrocardiographically in 1909.[1]In recent years it has become apparent that it is a cause of considerable morbidity and mortality. It is the most common cause of embolic stroke, accounting for approximately 75,000 strokes per year in the United States,[2]and leads to more hospital admissions than any other arrhythmia (Fig. 1 ).[3]In addition to causing symptoms of dizziness and dyspnea, AF may precipitate heart failure, syncope, angina, and myocardial infarction, and may trigger ventricular arrhythmias in susceptible individuals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
